Healthy adults
Conditions
Interventions
Intake cyclic dipeptide for 12 weeks
Intake placebo for 12 weeks
Sponsors
Shiba Palace Clinic
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Japanese males and females aged 60 to 75 years old at the time of informed consent 2) Subjects who feel that they are more forgetful compared with their younger days
Exclusion criteria
Exclusion criteria: 1) Subjects judged inappropriate for the study by the principal 2) Subjects who are participating in other clinical trials 3) Subjects who are taking medicines that can affect the test result 4) Subjects who are taking supplements that can affect the test result 5) Subjects who took RBANS by 3 months before the start of the test 6) Subjects who can be allergic to the test food 7) Subjects who have had a stroke, subarachnoid hemorrhage, cerebral infarction, cerebral hemorrhage, cerebral contusion, or head injury resulting in hospitalization for treatment or surgery 8) Excessive tobacco and alcohol users and those with extremely irregular eating habits 9) Subjects with medical history of hepatitis 10) Subjects with severe anemia 11) Subjects with medical history or medical treatments of Epileptic seizures, diabetes, thyroid dysfunction, or severe renal dysfunction (hemodialysis, uremia, anuria) 12) Subjects who have taken neuropsychological tests in the hospital
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| RBANS Cognitrax (before and 12 weeks after intake) | — |
Secondary
| Measure | Time frame |
|---|---|
| SF-36v2 WHO-5J body mass and BMI blood pressure, pulsation subjects' diary doctor's questions (before and 12 weeks after intake) | — |
Countries
Japan
Contacts
Public ContactMiwa Kaneko
SOUKEN Co., Ltd Management Division
Outcome results
None listed